Jamjoom Pharma
جمجوم فارماTechnical Analysis & Signals
Jamejoom Pharma stock shows a sideways trend with potential for price reversal.
Technical Analysis
The stock is currently trading at 141.6 SAR, with the RSI at 47.9 indicating a balance between buyers and sellers. Additionally, the positive MACD Hist value may suggest a potential upward movement in the future.
Support & Resistance Levels
The main support level for the stock is 140.5 SAR, while the resistance level is 143.3 SAR. The stock is expected to face challenges near the resistance level and may experience a bounce at the support level.
Volume Analysis
The current trading volume indicates moderate activity, reflecting a state of indecision among investors. A significant increase in trading volume could signal a strong upcoming price movement.
Fundamental Factors
The price-to-earnings (P/E) ratio stands at 20.6, indicating a moderate valuation of the stock relative to its earnings. Additionally, the dividend yield of 2.99% may attract some investors seeking steady income.
Risk Factors
Potential risks include general market volatility, especially with the trend of the TASI index. Additionally, any changes in economic or regulatory policies could impact the stock's performance.
Recommendation
Disclaimer: This analysis is for educational purposes only and does not constitute investment advice. Investors are advised to conduct their own research and review their investment strategies before making any decisions.
Financial Fundamentals
Price Data
Price Chart - Jamjoom Pharma
4015Technical Analysis
Moving Averages
Momentum Indicators
Bollinger Bands
Within BandTrend Strength (ADX)
Moderate TrendFinancial Summary
Valuation
- Market Cap
- 9.91B
- P/E Ratio
- 20.60
- P/B Ratio
- 5.30
- EPS (Earnings/Share)
- 6.87
Profitability
- Revenue
- 1.57B
- Net Income
- 480.59M
- Return on Equity (ROE)
- +27.00%
- Shares Outstanding
- 70.00M
Balance Sheet
- Total Assets
- 2.05B
- Total Debt
- 20.00M
- Debt/Equity
- 0.01
- Free Float %
- +34.3%
Dividends & Margins
- Dividend Yield
- +2.99%
- Dividend/Share
- 4.20
- Book Value
- 26.72
Financial data extracted from published quarterly reports. All values in SAR unless otherwise stated.
Historical Financial Data
5 years| Year | Revenue | Net Income | Total Assets | Total Debt | EPS |
|---|---|---|---|---|---|
| 2025 | 1.50B +13.8% | 463.80M +30.1% | 2.05B +15.5% | 16.43M +684.5% | 6.63 +30.3% |
| 2024 | 1.32B +19.8% | 356.52M +21.9% | 1.77B +7.1% | 2.09M -12.8% | 5.09 +21.8% |
| 2023 | 1.10B +20.1% | 292.40M +70.7% | 1.65B +17.5% | 2.40M -8.9% | 4.18 +70.6% |
| 2022 | 916.67M | 171.31M | 1.41B | 2.64M | 2.45 |
| 2021 | — | — | — | — | — |
Historical data sourced from Yahoo Finance and may differ from official audited financial reports.
Price Forecast
These forecasts are based on technical analysis and AI and do not constitute investment advice. Past performance does not guarantee future results.
News & Events
No news currently available for Jamjoom Pharma
Dividend History
Dividend data from Tadawul records. All amounts in SAR. Estimated yield calculated based on year-end price.
Ownership Structure
Data source: Yahoo FinanceLast updated: 2026-08-12
Risk Assessment
Risk Factors
Average True Range 2.1% of stock price
Trading volume near or above average
P/E ratio 20.6
Debt-to-equity ratio 0.01
ADX indicator at 34
Moderate risk factors with some sector pressures
This assessment is automated based on quantitative data and does not constitute investment advice. Please consult a licensed financial advisor before making investment decisions.
FAQ
1 What is Jamjoom Pharma stock price today?
Jamjoom Pharma (4015) stock price today is 141.60 SAR, gaining by +0.78% compared to the previous session close. The 52-week price range is between 121.15 SAR and 161.07 SAR.
2 What is Jamjoom Pharma stock valuation?
The automated analysis signal for Jamjoom Pharma is "Hold" with 65% confidence. The P/E ratio is 20.6. The P/B ratio is 5.30.
3 Is Jamjoom Pharma Shariah-compliant?
Yes, Jamjoom Pharma (4015) is Shariah-compliant according to the latest lists approved by relevant Shariah authorities.
4 What are Jamjoom Pharma dividend distributions?
Jamjoom Pharma has a dividend yield of 2.99%, with an estimated annual dividend of 4.20 SAR per share.
5 What is Jamjoom Pharma weekly performance?
Jamjoom Pharma performance over different time periods: weekly change -0.28%, monthly -0.75%, and year-to-date +1.46%. The stock is currently trading with a volume of 59,646 shares.
6 What is the target level for Jamjoom Pharma?
According to automated analysis for Jamjoom Pharma: Short-term target (1-2 weeks): 143.00 SAR. Support level: 140.50 SAR. Resistance level: 143.30 SAR. Note: These are automated analytical levels and do not constitute investment advice.
Disclaimer
The information provided on this page is for educational and analytical purposes only and does not constitute investment advice or a recommendation to buy or sell. Past performance does not guarantee future results. All investments involve risk including loss of capital. Please consult a licensed financial advisor before making any investment decisions.
Automated analysis relies on historical data and technical indicators and may not reflect future market conditions.